Enhertu Granted Priority Review in the US for Patients With

Press release content from Business Wire. The AP news staff was not involved in its creation.

Related Keywords

United States , Japan , Cambridge , Cambridgeshire , United Kingdom , Canada , America , Jessica Mcduell , Daiichi Sankyo , Ken Takeshita , Brendan Mcevoy , Susan Galbraith , Daiichi Sankyo Company , Drug Administration , Nasdaq , Company On Twitter Astrazeneca , Merck Co Inc , Astrazeneca , Investor Relations Team , European Medicines Agency , Lung Cancer Mutation Consortium , European Society For Medical Oncology , Biologics License Application , Priority Review , Prescription Drug User Fee Act , Real Time Oncology Review , Project Orbis , Executive Vice President , Global Head , European Society , Medical Oncology , Breakthrough Therapy Designation , North America , Clinical Cancer Advances , Molecular Profiling Driving Progress , Sankyo Company , Rare Diseases , Accessed January , Cancer Statistics , Mortality Worldwide , Pathol Transl , Natural History , Positive Breast Cancer Metastatic , New Targeted , Clin Breast , Future Management , Positive Metastatic Breast , Epidermal Growth Factor Receptor , Mol Biol , Lung Cancer Mutation , Business Wire , Business , Health , Cancer , Breast Cancer ,